1
John C Byrd, David M Goldenberg, Hans J Hansen: Anti-CD74 immunoconjugates and methods of use. The Ohio State University, Immunomedics, Richard A Nakashima, February 21, 2012: US08119101 (30 worldwide citation)

Disclosed are compositions that include anti-CD74 immunoconjugates and optionally a therapeutic and/or diagnostic agent. In preferred embodiments, the immunoconjugates comprise one or more anti-CD74 antibodies or antigen-binding fragments thereof, conjugated to a liposome or micelle. Also disclosed ...


2
Hans J Hansen, David M Goldenberg, Chien Hsing Chang: Anti-CD74 immunoconjugates and methods of use. Immunomedics, Rossi Kimms & McDowell, March 24, 2015: US08986699 (2 worldwide citation)

Disclosed are compositions that include anti-CD74 immunoconjugates and optionally a therapeutic and/or diagnostic agent. In preferred embodiments, the immunoconjugates comprise one or more anti-CD74 antibodies or antigen-binding fragments thereof, conjugated to a carrier such as a polymer, nanoparti ...


3
John C Byrd, David M Goldenberg, Hans J Hansen: Anti-CD74 immunoconjugates and methods of use. The Ohio State University, Immunomedics, Rossi Kimms & McDowell, September 30, 2014: US08846002 (2 worldwide citation)

Disclosed are compositions that include anti-CD74 immunoconjugates and optionally a therapeutic and/or diagnostic agent. In preferred embodiments, the immunoconjugates comprise one or more anti-CD74 antibodies or antigen-binding fragments thereof, conjugated to a liposome or micelle. Also disclosed ...


4
Hans J Hansen, David M Goldenberg, Chien Hsing Chang: Anti-CD74 immunoconjugates and methods of use. Immunomedics, Richard A Nakashima, February 26, 2013: US08383081

Disclosed are compositions that include anti-CD74 immunoconjugates and optionally a therapeutic and/or diagnostic agent. In preferred embodiments, the immunoconjugates comprise one or more anti-CD74 antibodies or antigen-binding fragments thereof, conjugated to a carrier such as a polymer, nanoparti ...


5
John C Byrd, David M Goldenberg, Hans J Hansen: Anti-CD74 immunoconjugates and methods of use. Immunomedics, Richard A Nakashima, February 5, 2013: US08367037

Disclosed are compositions that include anti-CD74 immunoconjugates and optionally a therapeutic and/or diagnostic agent. In preferred embodiments, the immunoconjugates comprise one or more anti-CD74 antibodies or antigen-binding fragments thereof, conjugated to a liposome or micelle. Also disclosed ...


6
Hans J Hansen, David M Goldenberg, Chien Hsing Chang: Anti-CD74 Immunoconjugates and Methods of Use. Immunomedics, Immunomedics, October 21, 2010: US20100266496-A1

Disclosed are compositions that include anti-CD74 immunoconjugates and optionally a therapeutic and/or diagnostic agent. In preferred embodiments, the immunoconjugates comprise one or more anti-CD74 antibodies or antigen-binding fragments thereof, conjugated to a carrier such as a polymer, nanoparti ...


7
John C Byrd, David M Goldenberg, Hans J Hansen: Anti-CD74 Immunoconjugates and Methods of Use. The Ohio State University, Immunomedics, Immunomedics, October 28, 2010: US20100272636-A1

Disclosed are compositions that include anti-CD74 immunoconjugates and optionally a therapeutic and/or diagnostic agent. In preferred embodiments, the immunoconjugates comprise one or more anti-CD74 antibodies or antigen-binding fragments thereof, conjugated to a liposome or micelle. Also disclosed ...


8
John C Byrd, David M Goldenberg, Hans J Hansen: Anti-CD74 Immunoconjugates and Methods of Use. Immunomedics, The Ohio State University, April 26, 2012: US20120100068-A1

Disclosed are compositions that include anti-CD74 immunoconjugates and optionally a therapeutic and/or diagnostic agent. In preferred embodiments, the immunoconjugates comprise one or more anti-CD74 antibodies or antigen-binding fragments thereof, conjugated to a liposome or micelle. Also disclosed ...


9
Anti-CD74 Immunoconjugates and Methods of Use. IMMUNOMEDICS, THE OHIO STATE UNIVERSITY, June 6, 2013: US20130142729-A1

Disclosed are compositions that include anti-CD74 immunoconjugates and optionally a therapeutic and/or diagnostic agent. In preferred embodiments, the immunoconjugates comprise one or more anti-CD74 antibodies or antigen-binding fragments thereof, conjugated to a liposome or micelle. Also disclosed ...


10
Anti-CD74 Immunoconjugates and Methods of Use. IMMUNOMEDICS, July 4, 2013: US20130171064-A1

Disclosed are compositions that include anti-CD74 immunoconjugates and optionally a therapeutic and/or diagnostic agent. In preferred embodiments, the immunoconjugates comprise one or more anti-CD74 antibodies or antigen-binding fragments thereof, conjugated to a carrier such as a polymer, nanoparti ...